Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
Purpose: This study evaluated serum amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels and echocardiography to determine their efficacy as markers for predicting postpartum pulmonary edema in patients with severe preeclampsia. Methods: We evaluated the NT-proBNP levels and echocardiogr...
| Published in: | Clinical and Experimental Obstetrics & Gynecology |
|---|---|
| Main Authors: | H.M. Kim, Y.S. Choo, W.J. Seong |
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2020-08-01
|
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/47/4/10.31083/j.ceog.2020.04.5301 |
Similar Items
The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)
by: Irina Cuciureanu, et al.
Published: (2021-03-01)
Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)
by: Chin-Shern Lau, et al.
Published: (2022-05-01)
Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01)
by: Andree G. Pearson, et al.
Published: (2025-08-01)
NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
by: Stefano Ciardullo, et al.
Published: (2022-11-01)
by: Stefano Ciardullo, et al.
Published: (2022-11-01)
Analytical and clinical performance evaluation of a new NT-proBNP assay
by: Pingfeng Feng, et al.
Published: (2024-07-01)
by: Pingfeng Feng, et al.
Published: (2024-07-01)
Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD
by: Li H, et al.
Published: (2020-01-01)
by: Li H, et al.
Published: (2020-01-01)
SST2 and NT-proBNP biomarkers in prediction of COVID-19
by: O.O. Samchuk, et al.
Published: (2023-06-01)
by: O.O. Samchuk, et al.
Published: (2023-06-01)
Role of Serum NT-proBNP Levels in Early Prediction of Prognosis in Severe COVID-19 Pneumonia
by: Hanife Usta Atmaca, et al.
Published: (2023-11-01)
by: Hanife Usta Atmaca, et al.
Published: (2023-11-01)
Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
by: Li H, et al.
Published: (2020-02-01)
by: Li H, et al.
Published: (2020-02-01)
Influence of growth and metabolic markers on hs-troponin T and NT-proBNP levels in healthy children
by: Alexandra Kiess, et al.
Published: (2023-09-01)
by: Alexandra Kiess, et al.
Published: (2023-09-01)
NT-proBNP as an Additional Marker of Significant Coronary Atherosclerotic Lesions
by: Oksana Yu. Marchenko, et al.
Published: (2021-12-01)
by: Oksana Yu. Marchenko, et al.
Published: (2021-12-01)
Setting the optimal threshold of NT‐proBNP and BNP for the diagnosis of heart failure in patients over 75 years
by: Emmanuelle Berthelot, et al.
Published: (2024-10-01)
by: Emmanuelle Berthelot, et al.
Published: (2024-10-01)
LSPR-Based Aptasensor for Rapid Urinary Detection of NT-proBNP
by: Maria António, et al.
Published: (2023-07-01)
by: Maria António, et al.
Published: (2023-07-01)
Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)
by: I. A. Kozlov, et al.
Published: (2023-02-01)
EVALUATION OF CORRELATION BETWEEN NT-proBNP BIOMARKER WITH RATES OF HEMODYNAMICS AND PULMONARY EXTRAVASCULAR WATER IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME
by: S. A. Komarov, et al.
Published: (2017-11-01)
by: S. A. Komarov, et al.
Published: (2017-11-01)
Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)
by: I. A. Kozlov, et al.
Published: (2023-10-01)
The Effect of Maximal and Submaximal Exercise Testing on NT-proBNP Levels in Patients with Systolic Heart Failure
by: Zdrenghea Dumitru Tudor, et al.
Published: (2014-03-01)
by: Zdrenghea Dumitru Tudor, et al.
Published: (2014-03-01)
Electrochemical Immunosensor for NT-proBNP Detection in Artificial Human Saliva: Heart Failure Biomedical Application
by: Elkahina Ghedir, et al.
Published: (2018-12-01)
by: Elkahina Ghedir, et al.
Published: (2018-12-01)
Dynamics of NT-proBNP and ST2 levels as markers of heart failure in patients with endogenous Cushing syndrome (hypercortisolism)
by: Raisa S. Kosharnaia, et al.
Published: (2023-01-01)
by: Raisa S. Kosharnaia, et al.
Published: (2023-01-01)
Determining the role of NT-proBNP levels in diabetic patients with heart failure: A study from North India
by: Merajul H. Siddiqui, et al.
Published: (2024-02-01)
by: Merajul H. Siddiqui, et al.
Published: (2024-02-01)
Prognostic value of the combination of uric acid and NT-proBNP in patients with chronic heart failure
by: Gülsüm Meral Yılmaz Öztekin, et al.
Published: (2022-05-01)
by: Gülsüm Meral Yılmaz Öztekin, et al.
Published: (2022-05-01)
NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients
by: Jinling Ma, et al.
Published: (2025-07-01)
by: Jinling Ma, et al.
Published: (2025-07-01)
Prognostic of NT-proBNP in heart failure patients with preserved, mid and reduced ejection fraction
by: Reynie Leonel Reinoso Gonella, et al.
Published: (2021-10-01)
by: Reynie Leonel Reinoso Gonella, et al.
Published: (2021-10-01)
NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
by: Paweł Komarnicki, et al.
Published: (2023-09-01)
by: Paweł Komarnicki, et al.
Published: (2023-09-01)
Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease
by: Jianping Liu, et al.
Published: (2025-04-01)
by: Jianping Liu, et al.
Published: (2025-04-01)
NT-proBNP Concentrations in the Umbilical Cord and Serum of Term Neonates: A Systematic Review and Meta-Analysis
by: Evangelos Christou, et al.
Published: (2022-06-01)
by: Evangelos Christou, et al.
Published: (2022-06-01)
GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)
The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease
by: Angeliki Mouzarou, et al.
Published: (2025-01-01)
by: Angeliki Mouzarou, et al.
Published: (2025-01-01)
The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
by: Gina Sado, et al.
Published: (2024-12-01)
by: Gina Sado, et al.
Published: (2024-12-01)
Linking Heart Function to Prognosis: The Role of a Novel Echocardiographic Index and NT-proBNP in Acute Heart Failure
by: Dan-Cristian Popescu, et al.
Published: (2025-08-01)
by: Dan-Cristian Popescu, et al.
Published: (2025-08-01)
NT-proBNP serves as a prognostic marker for adverse outcomes in severe immune checkpoint inhibitor-associated myocarditis
by: Cheng He, et al.
Published: (2025-10-01)
by: Cheng He, et al.
Published: (2025-10-01)
Clinical significance of NT-proBNP as a predictive biomarker of depressive symptoms in cardiac patients
by: Syeda Humayra, et al.
Published: (2025-04-01)
by: Syeda Humayra, et al.
Published: (2025-04-01)
N-terminal natriuretic propeptide type-b (NT-proBNP) and left ventricular ejection fraction in acute phase of st-segment elevation myocardial infarction and 1-year later
by: Jernej Markež, et al.
Published: (2007-11-01)
by: Jernej Markež, et al.
Published: (2007-11-01)
Relationship between Mildly Elevated NT-proBNP Levels and Heart Failure Stages in the Elderly
by: Rana A. Hallak, et al.
Published: (2024-10-01)
by: Rana A. Hallak, et al.
Published: (2024-10-01)
Paper Biosensor for the Detection of NT-proBNP Using Silver Nanodisks as Electrochemical Labels
by: Yi Peng, et al.
Published: (2022-06-01)
by: Yi Peng, et al.
Published: (2022-06-01)
Highly sensitive detection of NT-proBNP by molecular motor
by: Jie Zhang, et al.
Published: (2017-03-01)
by: Jie Zhang, et al.
Published: (2017-03-01)
Correlation between NT-proBNP, hsCRP and OXSR1: Clinical relevance in evaluating the prognosis of polytrauma patients
by: Costin Dumitru, et al.
Published: (2021-09-01)
by: Costin Dumitru, et al.
Published: (2021-09-01)
RETRACTED: N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE (NT-proBNP) IN STAGE 1 AND STAGE 2 HYPERTENSION PATIENTS
by: Supriati Wila Djami
Published: (2019-10-01)
by: Supriati Wila Djami
Published: (2019-10-01)
Macrophages in epicardial adipose tissue and serum NT-proBNP in patients with stable coronary artery disease
by: I. V. Kologrivova, et al.
Published: (2022-04-01)
by: I. V. Kologrivova, et al.
Published: (2022-04-01)
The Potential Role of Salivary NT-proBNP in Heart Failure
by: Aidonis Rammos, et al.
Published: (2023-08-01)
by: Aidonis Rammos, et al.
Published: (2023-08-01)
Similar Items
-
The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01) -
Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01) -
Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01) -
NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
by: Stefano Ciardullo, et al.
Published: (2022-11-01) -
Analytical and clinical performance evaluation of a new NT-proBNP assay
by: Pingfeng Feng, et al.
Published: (2024-07-01)
